Markets:

Overview

News

Currencies

International

Treasuries

Akero Therapeutics, Inc. - Common Stock (NQ:AKRO)

54.36 +0.01 (+0.02%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Akero Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗

November 09, 2025

Novo investors on Stocktwits praised new CEO Mike Doustdar as “dynamic,” saying they remain confident in Novo’s long-term obesity and diabetes pipeline despite short-term setbacks.

Via Stocktwits

Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk ↗

October 15, 2025

Novo Nordisk is licensing exclusive global rights to the company's experimental treatment for rare blood and kidney diseases.

Via Investor's Business Daily

This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

October 10, 2025

Via Benzinga

Wall Street Pulls Back as Earnings Season Kicks Off; PepsiCo, Delta, and Costco Defy the Trend ↗

October 10, 2025

U.S. markets took a step back on Thursday, with the Dow and Nasdaq closing lower. Still, some heavyweights bucked the trend: PepsiCo, Delta Air Lines, and Costco all reported stronger-than-expected...

Via Chartmill

Topics Stocks

This Stock Just Doubled in 1 Day -- Is It Still a Buy? ↗

February 02, 2025

Via The Motley Fool

Why Akero Therapeutics Stock Trounced the Market on Thursday ↗

October 09, 2025

The biotech will soon have a new owner.

Via The Motley Fool

Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today ↗

October 09, 2025

Via Stocktwits

Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday ↗

October 09, 2025

Via Benzinga

Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion ↗

October 09, 2025

Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion, adding EFX, a late-stage MASH treatment candidate, to its metabolic disease portfolio.

Via Benzinga

Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout ↗

October 09, 2025

The deal follows Roche's plan to buy 89bio, another MASH-focused biotech company.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 09, 2025

Via Benzinga

Dow Futures Inch Up As Wall Street Awaits Jerome Powell’s Speech: TSLA, NVO, DAL, PEP Among Stocks To Watch ↗

October 09, 2025

Via Stocktwits

Topics Economy Stocks

What’s Driving The Super Rally In Akero Shares On Thursday Morning? ↗

October 09, 2025

Novo Nordisk is set to acquire the firm, and Akero’s shareholders will receive $54 per share in cash at closing in addition to a contingent value right.

Via Stocktwits

Akero Therapeutics Inc (NASDAQ:AKRO) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Drive Investor Optimism ↗

August 08, 2025

Akero Therapeutics reports Q2 2025 results with narrower-than-expected loss, strong cash reserves, and promising clinical progress in MASH treatment. Stock gains 6.5% pre-market.

Via Chartmill

Akero (AKRO) Q2 Loss Narrows 6% ↗

August 08, 2025

Via The Motley Fool

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

August 04, 2025

Via Benzinga

AKERO THERAPEUTICS INC (NASDAQ:AKRO) - A Strong Technical Setup in Biotech ↗

July 18, 2025

AKERO THERAPEUTICS (NASDAQ:AKRO) shows strong technicals with a perfect 10 rating and a high-quality breakout setup, making it a stock to watch for traders.

Via Chartmill

Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased ↗

June 13, 2025

Jefferies thinks big pharma companies are "still on the hunt" for deals.

Via Stocktwits

Akero Therapeutics Stock Rallies To 3-Month High On Buyout Report; Retail Investors Turn Bullish ↗

May 20, 2025

The company reportedly hired an investment bank to explore a possible sale.

Via Stocktwits

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 20, 2025

Via Benzinga

Best Biotech Stocks to Buy in 2025

May 13, 2025

Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum.

Via MarketBeat

Topics ETFs Economy Government

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 01, 2025

Via Benzinga

The Stock Market Hates Uncertainty & Loves To Climb A Wall-Of-Worry ↗

March 21, 2025

In this video lesson, I review the overall market and a new swing position for Monday's session.

Via Talk Markets

Topics ETFs Stocks / Equities

10 Health Care Stocks Whale Activity In Today's Session ↗

March 21, 2025

Via Benzinga

3 Mid-Caps Worth Watching Closely in March

February 28, 2025

Unlike their mega-cap counterparts, which tend to grind, mid-caps can soar or crash within days, driven by headlines and pure speculation.

Via MarketBeat

Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? ↗

February 02, 2025

Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners...

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Royal Caribbean Cruises Posts Upbeat Earnings, Joins Brighthouse Financial, Invesco, Boeing And Other Big Stocks Moving Higher On Tuesday ↗

January 28, 2025

Via Benzinga

McDonald's To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

January 28, 2025

Via Benzinga

Which stocks are experiencing notable movement on Monday? ↗

January 27, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.